TABLE 1.
Clinical information for the four patient groups
Characteristica | Data for group: |
|||
---|---|---|---|---|
FT | FTA | PT | PTA | |
No. of vaginal samples | 18 | 18 | 22 | 24 |
No. of meconium samples | 21 | 26 | 21 | 24 |
No. of maternal GBS infections | 0 | 5 | 0 | 2 |
No. of premature rupture of membranes | 0 | 21 | 7 | 20 |
No. with amniotic fluid contamination (grade III) | 3 | 8 | 4 | 0 |
Gestational age (mean ± SD) (wk) | 39.42 ± 0.91 | 39.22 ± 1.03 | 35.17 ± 1.31 | 34.96 ± 1.51 |
Neonatal sex (no. of males: no. of females) | 16:8 | 15:12 | 13:11 | 11:14 |
Neonatal wt (mean ± SD) (g) | 3,106.25 ± 348.72 | 3,368.52 ± 344.93 | 2,558.33 ± 405.03 | 2,471.60 ± 329.27 |
Neonatal WBC count (mean ± SD) (109/liter) | 20.10 ± 5.51 | 18.20 ± 7.19 | 13.75 ± 6.85 | 12.57 ± 5.39 |
Neonatal CRP (mean ± SD) (mg/liter) | 1.23 ± 1.26 | 3.69 ± 8.98 | 0.99 ± 1.82 | 2.284 ± 6.34 |
No. with low birth wt | 1 | 0 | 9 | 12 |
No. with early-onset sepsis | 0 | 2 | 1 | 1 |
GBS, group B Streptococcus; WBC, white blood cell; CRP, C-reactive protein.